CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2017 Update

Summary

CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. CytoSorb is also being administered during and after cardiac surgery to prevent post-operative complications such as multiple organ failure. The company offers VetResQ, a blood purification adsorber, to help treat excessive inflammation and toxic injury in animals. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CytoSorbents Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

CytoSorbents Corp Company Overview 5
CytoSorbents Corp Company Snapshot 5
CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview 6
CytoSorbents Corp Pipeline Analysis Overview 9
CytoSorbents Corp - Key Facts 9
CytoSorbents Corp - Major Products and Services 10
CytoSorbents Corp Pipeline Products by Development Stage 11
CytoSorbents Corp Ongoing Clinical Trials by Trial Status 13
CytoSorbents Corp Pipeline Products Overview 15
BetaSorb 15
BetaSorb Product Overview 15
ContrastSorb 16
ContrastSorb Product Overview 16
CST 301 17
CST 301 Product Overview 17
CytoSorb 18
CytoSorb Product Overview 18
CytoSorb Clinical Trial 19
CytoSorb - Cytokine Release Syndrome 24
CytoSorb - Cytokine Release Syndrome Product Overview 24
CytoSorb-XL 25
CytoSorb-XL Product Overview 25
DrugSorb 26
DrugSorb Product Overview 26
HemoDefend 27
HemoDefend Product Overview 27
CytoSorbents Corp - Key Competitors 28
CytoSorbents Corp - Key Employees 29
CytoSorbents Corp - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
CytoSorbents Corp, Recent Developments 31
Mar 28, 2017: Cytosorbents Strengthens Intellectual Property Portfolio With New Patents Issued In The U.S., China, Japan, Russia, And Australia 31
Mar 27, 2017: CytoSorbents REFRESH I Trial Abstract Selected for Podium Presentation at the American Association for Thoracic Surgery Centennial Conference 31
Mar 22, 2017: Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins Cytosorbents Scientific Advisory Board 31
Mar 20, 2017: CytoSorb Treatment of HLH - The Parallel to Cytokine Release Syndrome in Cancer Immunotherapy 32
Mar 08, 2017: Cytosorbents Highlights Activities At The 22nd International Conference On Advances In Critical Care Nephrology 33
Mar 03, 2017: CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue 33
Feb 07, 2017: Cytosorbents To Present At The 19th Annual Bio CEO & Investor Conference 34
Jan 10, 2017: CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results 35
Dec 20, 2016: CytoSorbents Announces First Sales of New CytoSorb CPB Procedure Pack for Cardiac Surgery 35
Dec 12, 2016: Cytosorbents Receives $318,551 In Non-Dilutive Funding From The New Jersey Technology Business Tax Certificate Transfer Program 36
Appendix 37
Methodology 37
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview 6
CytoSorbents Corp Pipeline Products by Equipment Type 7
CytoSorbents Corp Pipeline Products by Indication 8
CytoSorbents Corp Ongoing Clinical Trials by Trial Status 8
CytoSorbents Corp, Key Facts 9
CytoSorbents Corp, Major Products and Services 10
CytoSorbents Corp Number of Pipeline Products by Development Stage 11
CytoSorbents Corp Pipeline Products Summary by Development Stage 12
CytoSorbents Corp Ongoing Clinical Trials by Trial Status 13
CytoSorbents Corp Ongoing Clinical Trials Summary 14
BetaSorb - Product Status 15
BetaSorb - Product Description 15
ContrastSorb - Product Status 16
ContrastSorb - Product Description 16
CST 301 - Product Status 17
CST 301 - Product Description 17
CytoSorb - Product Status 18
CytoSorb - Product Description 18
CytoSorb - Case-observation and Compassionate Use: Use of Extracorporeal Treatment with the Cytosorb-Adsorber for the Reduction of Postoperative Hyperinflammation and SIRS After Heart-surgery with the Use of a Heart-lung-machine 19
CytoSorb - Cytokine Adsorption in Sepsis and Acute Kidney Injury 19
CytoSorb - Cytokine Clearance with Cytoabsorbant Device During Cardiac Bypass: A Pilot Study 19
CytoSorb - Elimination of Antibiotics During Combined Continuous Renal Replacement Therapy and Cytosorb Adsorptive Therapy in Patients with Sepsis and Acute Kidney Injury 20
CytoSorb - Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy - A Randomized Study : EXCESS 20
CytoSorb - Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients with Rhabdomyolysis 20
CytoSorb - Immunomodulatory Effect of Extracorporeal Cytokine Adsorption in Cardiac Surgery 21
CytoSorb - International Registry on the Use of the CytoSorb-Adsorber in ICU Patients 21
CytoSorb - Myeloid-derived Supressor Cells in Uncomplicated Versus Complicated Patients after Cardiac Surgery 21
CytoSorb - Pancreatitis CytoSorbents (CytoSorb) Inflammatory Cytokine Removal: A Prospective Study 22
CytoSorb - Reduction of Inflammation Reaction to Extracorporeal Circulation in Cardiac Surgery by Interleukin Dialysis 22
CytoSorb - Removal of Cytokine on Cardiopulmonary Bypass with CytoSorb Compared to on- and Off-pump Myocardial Revascularization 22
CytoSorb - Removal of Cytokines During Cardiac Surgery 23
CytoSorb - The Effect of Early Cytokine Absorption on the Systemic Inflammatory Response Syndrome and Organ Dysfunction in the First 48 Hours of Septic Shock 23
CytoSorb - Cytokine Release Syndrome - Product Status 24
CytoSorb - Cytokine Release Syndrome - Product Description 24
CytoSorb-XL - Product Status 25
CytoSorb-XL - Product Description 25
DrugSorb - Product Status 26
DrugSorb - Product Description 26
HemoDefend - Product Status 27
HemoDefend - Product Description 27
CytoSorbents Corp, Key Employees 29
CytoSorbents Corp, Subsidiaries 30
Glossary 38

List Of Figures

CytoSorbents Corp Pipeline Products by Equipment Type 7
CytoSorbents Corp Pipeline Products by Development Stage 11
CytoSorbents Corp Ongoing Clinical Trials by Trial Status 13

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available